A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2025.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Maria Mulet und 14 weiteren Autor:innen. Beteiligte Einrichtung: Group of Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain. Hauptthemen laut MEDLINE: Neutrophils, Blood Platelets, Thrombocytopenia, Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Generalitat de Catalunya, Marathon Foundation of Tv3.
Abstract (Originalsprache)
BACKGROUND: Thrombocytopenia is frequently associated with increased mortality in sepsis; however, the underlying immunological mechanisms remain poorly understood. OBJECTIVES: This study characterizes molecular and phenotypic changes associated with thrombocytopenia in sepsis, focusing on platelets (PLTs), neutrophils, and their interactions, and evaluates their contributions to poor outcomes. METHODS: Blood samples were collected from 19 healthy donors, 27 nonthrombocytopenic (N-TP) and 22 thrombocytopenic (TP) patients with community-acquired sepsis at baseline (diagnosis), and at 24, 48, and 72 hours after admission. Plasma levels of PLT-derived mediators and neutrophil surrogate markers were quantified by ELISA. PLT and neutrophil phenotypes and neutrophil degranulation were assessed by flow cytometry, while extracellular DNA release, as a surrogate approximation of NETosis, was measured by SYTOX Green fluorescence and validated by myeloperoxidase (MPO)-DNA ELISA. RESULTS: TP patients showed higher percentages of PD-L1+ PLTs and increased CXCR4 expression on PLTs compared with N-TP patients. Their plasma also contained elevated soluble P-selectin and vascular endothelial growth factor levels. Compared with healthy donors, TP patients exhibited fewer neutrophil-PLT complexes; however, a greater proportion of these complexes were PD-L1+ and expressed higher CXCR4 levels than those in N-TP patients. Despite reduced extracellular DNA release upon stimulation, TP patients had higher plasma MPO-DNA complexes and MPO, neutrophil elastase, and S100A8/A9 levels. Clinically, TP patients had worse outcomes, with lower soluble CD40L levels and impaired in vitro extracellular DNA release correlating with disease severity (Sequential Organ Failure Assessment score ≥8). CONCLUSIONS: Our findings suggest a distinct immune signature in TP septic patients, defined by enhanced PLT activation and neutrophil dysfunction, potentially contributing to poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group of Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain.
- Infectious Diseases Division, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain.
- Infectious Diseases Division, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain; Universitat Autònoma de Barcelona, Cer…
- Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain; Department of Intensive Care, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Grup de Recerca Medicina Intensiva, Institut de Recerca Sant Pau (IR…
- Department of Intensive Care, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Grup de Recerca Medicina Intensiva, Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain.
- Unit of Haemostasis and Thrombosis, Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Förderung
- Generalitat de Catalunya
- Marathon Foundation of Tv3
Zitieren
APA
Mulet, M., Osuna-Gómez, R., Martínez-España, L., Artesero, I., Duch-Llorach, P., Vera-Artázcoz, P., Torrens-Sonet, M., Rodríguez-Farré, N., Vilalta, N., Abril-Gamboa, A., Seres, M., Cantó, E., Àngels Ortiz, M., López-Contreras, J., & Vidal, S. (2026). A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.09.006
Vancouver
Mulet M, Osuna-Gómez R, Martínez-España L, Artesero I, Duch-Llorach P, Vera-Artázcoz P, et al. A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.09.006
BibTeX
@article{Mulet2026,
author = {Mulet, Maria and Osuna-Gómez, Rubén and Martínez-España, Laura and Artesero, Iris and Duch-Llorach, Pol and Vera-Artázcoz, Paula and Torrens-Sonet, Maria and Rodríguez-Farré, Núria and Vilalta, Noelia and Abril-Gamboa, Andrés and Seres, Montserrat and Cantó, Elisabet and Àngels Ortiz, Ma and López-Contreras, Joaquín and Vidal, Silvia},
title = {A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2025.09.006}
}
EUVIMED